Lytton, Laurence W. 13D and 13G filings for Paratek Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 3:40 pm Sale | 2022-12-31 | 13G | Paratek Pharmaceuticals, Inc. PRTK | Lytton, Laurence W. | 459,961 0.800% | -2,750,591 (-85.67%) | Filing |
| 2022-05-18 4:47 pm Purchase | 2022-05-09 | 13G | Paratek Pharmaceuticals, Inc. PRTK | Lytton, Laurence W. | 3,210,552 5.900% | 3,210,552 (New Position) | Filing |